(AGENPARL) – BRUXELLES mar 02 maggio 2023 DRAFT OPINION on the proposal for a regulation of the European Parliament and…
Browsing: and
(AGENPARL) – SILVER SPRING mar 02 maggio 2023 Decentralized Clinical Trials for Drugs, Biological Products, and Devices Fonte/Source: http://www.fda.gov/regulatory-information/search-fda-guidance-documents/decentralized-clinical-trials-drugs-biological-products-and-devices
(AGENPARL) – GINEVRA (SVIZZERA) mar 02 maggio 2023 Article | Activities of the Pretoria regional delegation in 2022. The delegation supports…
(AGENPARL) – SILVER SPRING mar 02 maggio 2023 Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807…
(AGENPARL) – LONDON mar 02 maggio 2023 The Office for Health Improvement and Disparities (OHID) collects and publishes statistics on…
(AGENPARL) – BRUXELLES mar 02 maggio 2023 Opinion on the legal basis on the proposal for a Regulation of the…
(AGENPARL) – STRASBURGO mar 02 maggio 2023 REPORT on the proposal for a decision of the European Parliament and of…
(AGENPARL) – GINEVRA (SVIZZERA) mar 02 maggio 2023 Article | It is for this reason that we are launching a call…
(AGENPARL) – STRASBURGO mar 02 maggio 2023 REPORT on the proposal for a regulation of the European Parliament and of…
(AGENPARL) – STRASBURGO mar 02 maggio 2023 REPORT on the proposal for a regulation of the European Parliament and of…